Home › Funds › UBS Group AG › ABUS
UBS Group AG position in ABUS
ARBUTUS BIOPHARMA CORP · Health Care
Latest position (Q2 2026)249.21K sh
Reported value held$1.20M
Portfolio Weight0.00%
First reportedQ4 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 34.11K | $132.00K | New |
| Q1 2022 | 1.30K | $4.00K | Reduce |
| Q4 2022 | 23.29K | $54.26K | New |
| Q1 2023 | 36.66K | $111.09K | Add |
| Q2 2023 | 68.17K | $156.78K | Add |
| Q3 2023 | 62.62K | $127.11K | Reduce |
| Q4 2023 | 139.97K | $349.93K | Add |
| Q1 2024 | 134.82K | $347.84K | Reduce |
| Q2 2024 | 55.66K | $172.00K | Reduce |
| Q3 2024 | 168.37K | $648.24K | Add |
| Q4 2024 | 101.00K | $330.29K | Reduce |
| Q1 2025 | 192.29K | $671.10K | Add |
| Q2 2025 | 190.21K | $587.74K | Reduce |
| Q3 2025 | 774.59K | $3.52M | Add |
| Q4 2025 | 147.29K | $708.48K | Reduce |
| Q1 2026 | 364.47K | $1.64M | Add |
| Q2 2026 | 249.21K | $1.20M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ABUS
- Morgan Stanley 17.70M sh · $84.95M · Q2 2026
- BlackRock Inc 13.77M sh · $66.08M · Q2 2026
- Vanguard Group 9.24M sh · $44.46M · Q4 2025
- Geode Capital Management 4.12M sh · $19.77M · Q2 2026
- Goldman Sachs Group 3.51M sh · $16.83M · Q2 2026
- Bank of America Corp 2.65M sh · $12.70M · Q2 2026
- Legal & General Investment Management America 2.47M sh · $11.84M · Q2 2026
- Charles Schwab Investment Management 1.43M sh · $6.87M · Q2 2026
- Northern Trust Corp 1.42M sh · $6.81M · Q2 2026
- Citigroup Inc 879.24K sh · $4.22M · Q2 2026
- Arrowstreet Capital 650.70K sh · $3.12M · Q2 2026
- Wellington Management Group 461.65K sh · $2.22M · Q2 2026